Flag - 285x300

NHTSA’s Office of EMS Thanks You for Your Service

The Office of EMS (OEMS) at the National Highway Traffic Safety Administration (NHTSA) is celebrating our nation’s dedicated EMS clinicians during National EMS Week, May 15-21, 2022. We would like to thank you for your commitment to providing high-quality care and compassion to your patients. Your work makes your communities safer and healthier every day.

Please take a moment to watch this video to hear a special message from OEMS Director, Gam Wijetunge, expressing his heartfelt gratitude for EMS clinicians nationwide.

EMS Week Thank You Video


This year’s EMS Week theme is “Rising to the Challenge,” addressing the courage and perseverance EMS clinicians demonstrate every day. Despite the obstacles, EMS clinicians remain dedicated to treating patients in the face of a continued pandemic response while handling the typical challenges of working in EMS.

Take advantage of this opportunity to educate others about all that you and your fellow clinicians do, like Office of EMS EMS Specialist, Kate Elkins, featured on an episode of the Everything is Public Health podcast, scheduled for release on May 19, 2022.

From all of us here at the Office of EMS, NHTSA, and the Department of Transportation: Thank you.

NHTSA Names New 911 Program Coordinator

Please see the following statement from NHTSA announcing their newly named 911 Program Coordinator
911 program coordinator

The National Highway Traffic Safety Administration’s (NHTSA) Office of Emergency Medical Services announced today that Brian Tegtmeyer, ENP (Emergency Number Professional) will assume the role of National 911 Program Coordinator effective May 9, 2022. 

Mr. Tegtmeyer brings more than 26 years of experience in the field of public safety communications to the position.

“NHTSA’s long-term commitment to supporting 911 systems continues with the selection of Brian as the new coordinator for the National 911 Program,” said Gam Wijetunge, Director of the Office of EMS. “His deep knowledge of 911 systems and history of working within the 911 community, at a state, regional and national level is the experience needed to collaborate on updating and improving 911 across the nation.”

Brian began his career as a dispatcher at Hazel Crest Illinois Police Department and continued serving in various leadership roles in 911 systems before assuming his most recent position as Executive Director of DuPage Public Safety Communications in 2007. There he managed a 911 center with 44 agencies that serves a population of over 850,000 citizens.

“Next Generation 911 is the future of public safety communications. This evolution will impact every aspect of a communications center from the technology to operations to our most valuable resource—our telecommunicators,” said Tegtmeyer. “I am excited to join the National 911 Program’s efforts to help state and local 911 systems provide optimal 911 services to their communities.”

Brian has spent over a decade as a national educator teaching Public Safety Telecommunicator courses. He has also been an active member of multiple public safety organizations, including the National Emergency Number Association (NENA), the Association of Public Safety Communications Officials (APCO) and has been active in Telecommunicator Emergency Response Taskforces (TERT) on a state and national level.

Brian earned a Bachelor of Arts degree in Criminal Justice and Sociology at Western Michigan University and also served as a firefighter-EMT at the start of his career.

VHA Office of Community Care Overview

From VHA Train

In this series of live webinars provider participants will receive an overview of Community Care which includes the background on Community Care programs and the corresponding VA regulations. In-dept discussions on topics from referrals and authorizations, authorized emergency and unauthorized emergency care, urgent care, claims, and more. This webinar will take place in February, April, June, and August in 2022.

Prior to the webinar, please send any questions you have to vha13communitycaresupportstaff@va.gov +

Register Now

Mar 17, 2022
1:00 pm EST

Apr 21, 2022
1:00 pm EST

May 19, 2022
1:00 pm EST

Jun 16, 2022
1:00 pm EST

Jul 21, 2022
1:00 pm EST

Aug 18, 2022
1:00 pm EST

Sep 15, 2022
1:00 pm EST

Application Period Extended for FY 2021 Assistance to Firefighters Grant (AFG) Program

Please see the below notice from FEMA on the extension of the Assistance to Firefighter Grant (AFG) Program:

“FEMA has been working with the General Services Administration to resolve interface issues related to SAM.gov that were affecting some applicants’ ability to begin inputting their federal fiscal year (FY) 2021 Assistance to Firefighters Grant (AFG) Program applications into the FEMA GO System. Specifically, this issue included applicants that received error messages stating their organizations were not found and that their Unique Entity Identifier (UEI)/Electronic Funds Transfer (EFT) combination did not exist despite the applicants’ SAM.gov accounts being fully active.

As this issue is ongoing, the FY 2021 AFG Program application period will remain open until January 21, 2022 5:00 p.m. ET. All applicants will automatically be granted this extension. This ensures that applicants affected by the UEI/EFT issue will have sufficient time to complete the online application. The extension to the application period will not affect the award timeline. In the meantime, FEMA continues to strongly encourage applicants to review the FY 2021 AFG Program Notice of Funding Opportunity and the associated tools posted on the FEMA website here: FY 2021 Assistance to Firefighters Grant (AFG) Application Guidance Materials | FEMA.gov. In preparation for application submission, applicants may also draft their narratives separately and cut and paste them into the appropriate areas of FEMA GO once the SAM.gov interface issue is resolved. The questions that are asked in the narrative section may be found in the FY 2021 AFG Program Narrative Get Ready Guide.

Fire Grants Help Desk: If you have questions about the NOFO or application process, call or email the Fire Grants Help Desk. The toll-free number is 1-866-274-0960; the e-mail address for questions is firegrants@fema.dhs.gov.The Fire Grants Help Desk is open Monday – Friday, 8 a.m. – 4:30 p.m. ET. “

 

HRSA Announces Distribution of Phase 4 General Distribution Funds

The Health Resources & Services Administration (HRSA) has announced that it will begin distributing Phase 4 General Distribution Payments on Thursday, December 16, 2021.  According to HRSA, approximately 75% of all Phase 4 applications have now been processed.  HRSA indicated that the remaining 25% of applications require additional review under its risk mitigation and cost containment safeguards.

HRSA further indicated that it began distributing American Rescue Plan (ARP) Rural Payments on November 23, 2021.  As of December 14, 2021, HRSA has indicated that it has processed approximately 96% of ARP applications.  The ARP allocated a total of $8.5 billion to health care providers who serve rural Medicare, Medicaid and CHIP patients.  HRSA indicated that it will distribute $7.5 billion of these funds in its initial distribution.

To the extent a provider was determined to be eligible for either a Phase 4 payment or an ARP Rural Payment, the provider will receive both an email notification and a paper letter with additional details on these payments.  This will include the individual amounts attributed to any subsidiary TINs submitted as part of their application.  To the extent HRSA determined that you were not eligible for a Phase 4 payment, the email notice will provide an explanation for why you were determined to be ineligible.  These email notices will be sent to the email address provided in the Phase 4 application.  Providers selected for additional review will receive email notification as soon as HRSA completes its review process, which it indicated would be completed in “early 2022.”

AAA members are encouraged to look for this email.  If you have not received an email notification, we would suggest that you check your spam filter, as several of our members have indicated that the email was flagged as “spam” by their email system. 

Call to Action: Write Your Members of Congress Today!

Our nation’s EMS infrastructure is at risk. Ground ambulance service organizations are facing a financial crisis due to the lack of adequate reimbursement for their services and a crippling shortage of paramedics and EMTs. If Congress does not act soon, the situation will become worse with an additional 4% sequestration cut for all Medicare providers and suppliers including for ground ambulance services. Our nation’s 9-1-1 EMS infrastructure is at risk.

Place follow the link below to contact your members of Congress and ask that they protect ground emergency and non-emergency ambulance services in our communities.

Contact your Members of Congress

TODAY | CMS Cost Data Collection System Q&A Session

CMS Medicare Ground Ambulance Data Collection Q&A Session

Tuesday, September 14 from 2-3 pm ET

CMS is hosting a Q&A session about the Medicare Ground Ambulance Data Collection System tomorrow at 2:00pm Eastern.

Do you have questions about the Medicare Ground Ambulance Data Collection System? Join this live Q&A session. You may also send questions in advance to AmbulanceDataCollection@cms.hhs.gov with “September 14 Q&A” in the subject line. We’ll update documents on our Ambulances Services Center webpage with answers to common questions from this session.

More Information:

Register for this session

 

NEMSIS | EMS Body Cam Guide

New Guide Offers Body-Worn Camera Legal Considerations for EMS Agencies

Although body-worn cameras aren’t yet widely used in EMS, interest is growing and organizations that have employed them have seen significant benefits – and some limitations.

To help guide agencies, the National Emergency Medical Services Information System Technical Assistance Center (NEMSIS TAC), in cooperation with the legal firm Page, Wolfberg & Wirth, has released the EMS Body-worn Camera Quickstart Guide: Legal Considerations for EMS Agencies. The guide provides an overview of general legal issues for EMS agencies thinking about using body-worn cameras.

An overview of these key legal considerations for EMS agencies are covered in the new document:

  • Federal HIPAA standards
  • State invasion of privacy laws
  • State wiretap/eavesdropping laws
  • State open records laws
  • Data retention requirements
  • Developing a body-worn camera policy

Every EMS agency considering the use of body-worn cameras must evaluate not just legal issues but financial considerations, public perception, impact on staff, potential union bargaining and more.

Download PDF

de Beaumont | COVID-19 Vaccine Acceptance Language

From the de Beaumont Foundation

The findings of a new national poll, “The Language of Vaccine Acceptance,” reveal the urgent need for political and health leaders to adjust their messaging to improve confidence in COVID-19 vaccines. The poll identifies the language that will be most effective in reaching all Americans, especially those who are currently less likely to take a vaccine, including rural Americans, Republicans age 18-49, Black Americans 18-49, and women 18-49.

The nationwide poll was conducted by the de Beaumont Foundation and pollster Frank Luntz in partnership with the American Public Health Association, the National Collaborative for Health Equity, and Resolve to Save Lives, an Initiative of Vital Strategies.

Highlights

  • Sixty percent of Americans said they were either “absolutely certain” or would “probably” get the vaccine if they could now.
  • The groups least likely to say they were “absolutely certain” were Americans in rural/farm communities (26%), Republicans age 18-49 (27%), Black Americans 18-49 (28%), and women 18-49 (29%). This compares with 41% of all respondents who said they were “absolutely certain” they would get the vaccine.
  • When asked about the biggest concern about taking the COVID-19 vaccine, one-third of all respondents (33%) said either long-term side effects or short-term side effects. The top three statements about side effects that respondents found most reassuring were “the likelihood of experiencing a severe side effect is less than 0.5%,” mild side effects “are normal signs that their body is building protection,” and “most side effects should go away in a few days.”
  • When asked what they want most from a vaccine, respondents said “a return to normal,” followed by “safety” and “immunity.”
  • When asked which statement was the most convincing, 62% of respondents chose “getting vaccinated will help keep you, your family, your community, the economy, and your country safe and healthy” over “taking the vaccine is the right thing to do for yourself, for your family, your community, the economy, and the country” (38%). This highlights the need to avoid moralizing and lecturing Americans when it comes to the importance of vaccine acceptance.
  • Family is by far the most powerful motivator for vaccine acceptance. Significantly more Americans said they’d be most willing to take the vaccine for their family as opposed to “your country,” “the economy,” “your community,” or “your friends.”
  • The most convincing reasons to take the vaccine were “at 95 percent efficacy, this vaccine is extraordinarily effective at protecting you from the virus” and “vaccines will help bring this pandemic to an end,” and “getting vaccinated will help keep you, your family, your community, and your country healthy and safe.”

Continue Reading

CMS Announces Ambulance Services Selected for Year 2 Data Collection

The Centers for Medicare and Medicaid Services (CMS) has announced the names of those ground ambulance service providers and suppliers who will be required to submit their data for year 2 under the ambulance data collection system. To see the list of providers and suppliers selected for year 2, please go to the Ambulances Services Center page of the CMS website and scroll down to “Ground Ambulance Providers and Suppliers Selected to Submit Data in Year 2 (Zip)” or click here to download the file directly.

Those providers and suppliers selected for either year 2 or year 1 will need to capture and report their data for a 12-month period beginning between January 1, 2022 and December 31, 2022. Providers and suppliers will have 5 months from the end of their reporting period in which to submit their data to CMS. CMS delayed the capturing and reporting of ambulance data due to the COVID-19 public health emergency.

Download List (ZIP file)

GAO | Safety: States and DOT Are Implementing Actions to Reduce Roadside Crashes

From the US General Accountability Office on December 17

First responders stopped on the side of the road risk being struck by passing vehicles. To protect these workers, all states and D.C. enacted “Move Over” laws that require motorists to move over to another lane or slow down when they pass a roadside incident.

The Department of Transportation helps state officials educate the public about Move Over laws and administers funding that state officials can use for enforcement efforts. It also trains first responders in protecting themselves on the roadside.

The Department is planning to study motorist behaviors that contribute to roadside incidents and technologies that protect first responders.

Survey of COVID-19 Impact on EMS Staffing

The American Ambulance Association has partnered with the National Association of Emergency Medical Technicians (NAEMT) and the International Association of Fire Chiefs (IAFC) to create a workforce survey assessing the impacts of COVID-19 on staffing levels at fire and EMS agencies.

Please take a few minutes of your time to complete this brief survey, which will help inform our federal partners of the impact that the Public Health Emergency has had on our industry’s staffing.

You can view real time survey results on our public dashboard► 

Take Survey Here

Ambulance Decontamination White Paper

Published by Demers-Braun-Crestline
866-636-0415 (US)
866-667-0856 (CA)
514-971-4509 (Intl)

COVID-19 is the present-day challenge facing our first responders, but infectious diseases have always posed a threat to EMS personnel and their patients. Developed with insights and internal testing from engineering resources at Demers-Braun-Crestline, the white paper aims to identify verified solutions to reducing the spread of infectious diseases inside an ambulance. Highlighted are five key areas of focus; each is discussed in-depth to help identify why it is important and what proven options are available to implement inside an ambulance.

The white paper includes a detailed overview of each of these, helping to educate readers on ambulance options and features that assist in limiting the spread of viruses, bacteria, parasites, and fungi. From plexiglass dividers to HEPA filters, chemical fogging systems to self-disinfecting surfaces, and everything in-between, this white paper outlines a variety of solutions that every emergency response organization should consider for protecting patients and personnel from infectious diseases.

Download the White Paper online for free

 

NAAC Live 2020 Offers All Four Certification Courses

NAAC Live 2020 Offers All Four Certification Courses with Live, Real Time Instruction

 

Press Release Contact:  
Jason Leet, Program Coordinator at 717-620-2692
j.leet@AmbulanceCompliance.com

NAAC® – The National Academy of Ambulance Compliance for the first time ever is hosting all four NAAC certification programs at one virtual event – live and in real time – over two weeks in September.  Each course features live instructors that will answer questions in real time.  “These live courses offer an unparalleled opportunity to obtain all NAAC ambulance certification credentials in a dynamic and interactive setting,” said program coordinator Jason Leet.  “Course enrollees will get all their questions answered live,” Leet said.

NAAC Live 2020 is different from the traditional, self-paced online courses offered by NAAC, according to Leet. During NAAC Live 2020, the courses will be presented live on specific class schedules:

Certified Ambulance Compliance Officer™ – CACO®
September 9 through 10, 2020

Certified Ambulance Coder® – CAC®
September 14 through 16, 2020

Certified Ambulance Privacy Officer™ – CAPO®
September 21 through 22, 2020

Certified Ambulance Documentation Specialist™ – CADS® –
September 24, 2020

There is a registration fee for each course, which includes all course educational materials and includes the testing and certification process.  Click HERE to register or obtain additional information.

“This schedule allows attendees to obtain all four of our certifications in a two-week time span as courses are staggered so there is no overlap,” added Leet. Instructors are attorneys and consultants of the national EMS law firm of Page, Wolfberg & Wirth, LLC, the nation’s leading EMS law firm – experts in ambulance industry compliance. In addition to the live instruction, course enrollees will have immediate access to each final exam, and there will be instant certification upon completion and passing the exam, said Leet.

About the Courses

The CAC course is designed for ambulance billing personnel – anyone involved in the ambulance revenue cycle. This includes front line ambulance billers and coders, billing office supervisors and managers, compliance officers, QA coordinators and upper level management in an ambulance service, billing company or any other entity involved in ambulance billing, reimbursement, or revenue cycle management.

The CACO course is recommended for current and prospective compliance officers, upper level management, advanced billers and coders, and anyone involved in compliance training or supervising compliance with the ambulance billing company or agency.

The CAPO course is designed for the prospective HIPAA Compliance Officer/Official, Privacy Officer, security officers, managers, supervisors, and others involved in HIPAA training or compliance.

The CADS course is intended for front-line EMS practitioners, as well as ambulance industry leadership, revenue cycle management, compliance, quality improvement and other support positions. The CADS course covers the essential documentation skills necessary to facilitate high quality patient care, reduce provider and agency liability, improve clinical documentation, and facilitate accurate billing.

About NAAC

NAAC – The National Academy of Ambulance Compliance – is the nation’s leader in ambulance compliance education. NAAC represents the industry’s “Gold Standard of Excellence” in compliance, ethics, and legal integrity in all facets of ambulance compliance. NAAC provides premier training and education to ambulance billing, coding and compliance professionals and EMS practitioners through its four certification programs.

NAAC-certified professionals maintain their competency through annual continuing education requirements. NAAC provides and accredits a wide range of continuing education programs throughout the year, both in classroom and online offerings.

Certified individuals – including those obtaining certifications during NAAC Live 2020 – can meet all their annual required continuing education requirements by attending the PWW XI/abc360 conferences, to be held October 20-22, also as live, virtual events.  CLICK HERE for information about the Fall Conference.

More detailed information on NAAC and its ambulance industry certification courses can be found online at www.AmbulanceCompliance.com.

###

COVID-19 Testing for First Responders

From the Federal Healthcare Resilience Task Force’s EMS / Prehospital Team on July  2.

COVID-19 Testing for First Responders

Product (EMS42) Purpose

This document provides a brief overview of COVID-19 testing to inform decision-making for first responders including emergency medical service (EMS), Fire & Rescue, Law Enforcement and 911 telecommunicators.

Developed By

The Federal Healthcare Resilience Task Force (HRTF) is leading the development of a comprehensive strategy for the U.S. healthcare system to facilitate resiliency and responsiveness to the threats posed by COVID-19. The Task Force’s EMS/Pre-Hospital Team is comprised of public and private-sector EMS and 911 experts from a wide variety of agencies and focuses on responding to the needs of the pre-hospital community. This team is composed of subject matter experts from the National Highway Traffic Safety Administration (NHTSA) Office of Emergency Medical Services (OEMS), National 911 Program, Federal Emergency Management Agency (FEMA), U.S. Fire Administration (USFA), U.S. Army, U.S. Coast Guard (USCG), Department of Homeland Security (DHS) Cybersecurity and Infrastructure Security Agency (CISA) and non-federal partners representing stakeholder groups. Through collaboration with experts in related fields, the team develops practical resources for field providers, supervisors, administrators, medical directors, and associations to better respond to the COVID-19 pandemic.

Intended Audience

State, Local, Tribal, and Territorial Governments (SLTTs), First Responders (Law Enforcement, Fire & Rescue, Emergency Medical Services (EMS) and 911 communication personnel).

Expected Distribution Mechanism

EMS.gov, Stakeholder Calls, EMS stakeholder organization’s membership distribution Email mechanisms, USFA website, Social Media posts. Request assistance distributing to FEMA/HHS RECs

Internal Routing Review

NRCC (for approval), All ESFs and HCRTF Teams & Threads (for SA only)

Primary Point of Contact

NHTSA Office of EMS, nhtsa.ems@dot.gov, 202-366-5440

Date Published: July 2, 2020

COVID-19 Testing for First Responders

Purpose: This document provides a brief overview of COVID-19 testing to inform decision- making for first responders including emergency medical service (EMS), Fire & Rescue, Law Enforcement and 911 telecommunicators.

1. Overview of testing for SARS-CoV-2 (the virus that causes the disease COVID-19):

The Food and Drug Administration (FDA) is the U.S. government entity responsible for regulating medical devices, including tests and devices like those being used to detect SARS-CoV-2. Because of the public health emergency caused by a previously unknown novel coronavirus, the FDA has issued multiple Emergency Use Authorizations (EUA) for various types of medical devices, including tests. Final validation of these tests still need to be completed through all of the normal FDA clearance criteria and received approval or clearance by the FDA under the traditional marketing pathways approval processes at this time. A list of tests which have been issued EUAs is available at EUA Information: gov.

2. Types of Testing:

  • Molecular: The molecular diagnostic tests look for evidence of an active infection by detecting either the genetic material of the pathogen or a unique marker of it. This type of test detects signs of the virus’s genetic material. One type of molecular testing uses is called a reverse transcriptase – polymerase chain reaction (RT-PCR) for pathogen detection. This approach requires only a small sample size of the pathogen (ex. from blood or saliva) and amplifies segments of the virus’ genetic code and replicates it in order to be show it is present more easily detected. A positive result indicates the presence of actual infectious viral material in the body. However, these results cannot alone determine if the pathogen remains viable (e.g., infective) or is dead and no longer infective. The presence of such material does not necessarily indicate if the patient is infectious (although for provider safety, patients with a positive test should be presumed infectious) but simply that such material is there. Test samples are usually obtained from humans using a special nasal swab designed for this
  • Antigen: The antigen diagnostic tests quickly detect fragments of pathogen proteins found on or within the virus from testing samples collected from humans, often from a swab of the nasopharyngeal cavity using swabs. However, antigen tests may not detect all active infections. Antigen tests are very specific for the virus but are often not as sensitive as molecular RT-PCR tests because of the certainty of positive samples used to develop the actual test. This means that while positive results from antigen tests are generally highly quite accurate, but there is also a higher chance of false negatives – which means falsely claiming absence of infection, thus negative results do not rule out infection. Until well-validated antigen testing is available, negative results from this approach may warrant confirmatory testing using a molecular test (i.e. an antigen test may need to be confirmed with a RT-PCR test prior to making treatment decisions or to help prevent the possible spread of the virus due to a false negative).
  • Serological: The serology tests look for the presence of antibodies, which are specific proteins made in response to an infection as part of the body’s attempt to fight that infection. It does not specifically indicate current (active) disease. It is important to remember that development of antibodies takes some time to develop after exposure to the infection, usually weeks. There are also different types of antibodies that are developed and can be tested for individually (ie. IgG, IgM). Depending on when someone was infected and the timing of the test, antibodies may not have developed in sufficient quantities to be detected by the test. We currently don’t know if detection of antibodies, and at what level, indicates immunity, and/or protection, from a future exposure. Similarly, there is also, another concern that any detected antibodies may instead reflect other strains of a more commonly occurring coronaviruses, such as those causing which causes some variations of the common

3. Testing Limitations: No test is 100% accurate 100% of the time.

  • Specificity: Specificity is a measures of a test’s ability to correctly generate a negative result for people who don’t have the condition that’s being tested for (also known as the “true negative” rate). A high-specificity test will correctly rule out almost everyone who doesn’t have the disease when the test is negative and won’t generate a high percentage of false-positive results. (Example: a test with 90% specificity will correctly return a negative result for 90% of people who don’t have the disease but will return a positive result — a false-positive — for 10% of the people who don’t have the disease and should have tested negative – which is termed a false positive )
  • Sensitivity: Sensitivity is a measures of how often a test correctly generates a positive result for people who have the condition that’s being tested for (also known as the “true positive” rate). A test that’s highly sensitive will identify almost everyone who has the disease and not generate many false-negative results. (Example: a test with 90% sensitivity will correctly return a positive result for 90% of people who have the disease but will return a negative result — a false-negative — for 10% of the people who have the disease and should have tested positive, or a false )
  • There are currently a variety of tests which have not been reviewed by FDA but may be purchased to test for COVID-19. The concern with false negatives relates to the higher potential for future transmission whereas the concern for a false positive relates to unnecessary additional diagnostic or medical procedures for the patient and wasted unnecessary PPE use for the provider and a false negative result could lead to additional exposure to contacts of the patient, including first responders and EMS personnel.

4. Testing Evaluation Tips:

Testing for first responders and EMS clinicians should be coordinated with the EMS Medical Director and other local/state public health

Check the FDA site (COVID-19 Testing EUA Recipients ) to determine whether the test you are considering purchasing has received an EUA by the

Work with the EMS Medical Director to identify the test error rate to determine whether the results can be relied upon and if actions can be made with the data

Purchase tests only through verified suppliers to ensure authenticity. There have been reports of counterfeit tests being sold to unsuspecting

Follow the test instructions exactly to avoid increasing the error rate and to achieve full test performance. Use Clinical Laboratory Improvement Amendments (CLIA)-certified labs for test processing, if required based on the specific

5. Research References:

CDC Serology Testing: https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html

Emergency Use Authorizations: https://www.fda.gov/medical-devices/emergency-use- authorizations-medical-devices/coronavirus-disease-2019-covid-19-emergency-use- authorizations-medical-devices

FAQs on Diagnostic Testing for SARS-CoV-2: https://www.fda.gov/medical-devices/emergency- situations-medical-devices/faqs-diagnostic-testing-sars-cov-2

FDA Contact Information on Testing:

FDA Statement Regarding COVID-19 Antigen Testing: https://www.fda.gov/news-events/press- announcements/coronavirus-covid-19-update-fda-authorizes-first-antigen-test-help-rapid- detection-virus-causes

Serology Test FAQs: https://www.fda.gov/medical-devices/emergency-situations-medical- devices/faqs-diagnostic-testing-sars-cov-2#serology

CDC recommendations for the Testing of COVID 19: https://www.cdc.gov/coronavirus/2019- ncov/symptoms-testing/testing.html

Infectious Disease Society of America (IDSA) primer on serological testing : https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-covid-19-antibody- testing-primer.pdf*

Guidance on Interpreting COVID-19 Test Results: https://www.whitehouse.gov/wp- content/uploads/2020/05/Testing-Guidance.pdf

CISA Guidance on Essential Critical Infrastructure Workers

ADVISORY MEMORANDUM ON IDENTIFICATION OF ESSENTIAL CRITICAL
INFRASTRUCTURE WORKERS DURING COVID-19 RESPONSE

As the Nation comes together to slow the spread of COVID-19, on March 16th the President issued updated Coronavirus Guidance for America that highlighted the importance of the critical infrastructure workforce.

The Cybersecurity and Infrastructure Security Agency (CISA) executes the Secretary of Homeland Security’s authorities to secure critical infrastructure. Consistent with these authorities, CISA has developed, in collaboration with other federal agencies, State and local governments, and the private sector, an “Essential Critical Infrastructure Workforce” advisory list. This list is intended to help State, local, tribal and territorial officials as they work to protect their communities, while ensuring continuity of functions critical to public health and safety, as well as economic and national security. Decisions informed by this list should also take into consideration additional public health considerations based on the specific COVID-19-related concerns of particular jurisdictions.

This list is advisory in nature. It is not, nor should it be considered, a federal directive or standard. Additionally, this advisory list is not intended to be the exclusive list of critical infrastructure sectors, workers, and functions that should continue during the COVID-19 response across all jurisdictions. Individual jurisdictions should add or subtract essential workforce categories based on their own requirements and
discretion. The advisory list identifies workers who conduct a range of operations and services that are typically essential to continued critical infrastructure viability, including staffing operations centers, maintaining and repairing critical infrastructure, operating call centers,
working construction, and performing operational functions, among others. It also includes workers who support crucial supply chains and enable functions for critical infrastructure. The industries they support represent, but are not limited to, medical and
healthcare, telecommunications, information technology systems, defense, food and agriculture, transportation and logistics, energy, water and wastewater, law enforcement,  and public works.

State, local, tribal, and territorial governments are responsible for implementing and executing response activities, including decisions about access and reentry, in their communities, while the Federal Government is in a supporting role. Officials should use their own judgment in issuing implementation directives and guidance. Similarly, while adhering to relevant public health guidance, critical infrastructure owners and operators are expected to use their own judgement on issues of the prioritization of business processes and workforce allocation to best ensure continuity of the essential goods and
services they support. All decisions should appropriately balance public safety, the health and safety of the workforce, and the continued delivery of essential critical infrastructure services and functions. While this advisory list is meant to help public officials and employers identify essential work functions, it allows for the reality that some workers engaged in activity determined to be essential may be unable to perform those functions
because of health-related concerns.

CISA will continue to work with our partners in the critical infrastructure community to
update this advisory list if necessary as the Nation’s response to COVID-19 evolves.
Should you have questions about this list, please contact CISA at CISA.CAT@cisa.dhs.gov.

Download as a PDF

Savvik | Clarity COVID-19 IgG/IgM test kits

Available through our partners at Savvik Buying Group!

$599.80 per Box of 20

  • Chromatographic immunoassay polymerase chain reaction/IgG/IgM test
  • Results in 3-7 minutes
  • Not just binary positive/negative; rather, spectrum of 7 possible results include window period through active infection and post/recovered
  • Self-contained test cassettes; no need for secondary capital equipment
  • Sold by Clarity Diagnostics, a licensed American pharmacy, manufactured by Alfa Scientific Designs of Poway, CA
  • Authorized for use under March 16, 2020 guidance from FDA (attached for convenience), part IV.
  • Clear Vision – Clear Results  Clarity COVID-19 IgM/IgG Rapid Test Kit The Clarity COVID-19 IgM/IgG Rapid Test Kit is an ideal complement to nucleic acid detection. PCR and COVID-19 IgM/IgG Rapid Test are often used in synergy to complement each other, improving diagnosis efficiency and monitor disease progression.

Shop Now at Savvik